- Home
- NIVF vs ISPC Comparison
NIVF vs ISPC Comparison
Compare NIVF & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIVF
- ISPC
- Stock Information
- Founded
- NIVF 2011
- ISPC 2009
- Country
- NIVF Hong Kong
- ISPC United States
- Employees
- NIVF N/A
- ISPC N/A
- Industry
- NIVF
- ISPC Precision Instruments
- Sector
- NIVF
- ISPC Health Care
- Exchange
- NIVF NYSE
- ISPC Nasdaq
- Market Cap
- NIVF 5.2M
- ISPC 4.7M
- IPO Year
- NIVF N/A
- ISPC 2021
- Fundamental
- Price
- NIVF $0.35
- ISPC $3.00
- Analyst Decision
- NIVF
- ISPC
- Analyst Count
- NIVF 0
- ISPC 0
- Target Price
- NIVF N/A
- ISPC N/A
- AVG Volume (30 Days)
- NIVF 6.4M
- ISPC 378.8K
- Earning Date
- NIVF 02-16-2025
- ISPC 11-07-2024
- Dividend Yield
- NIVF N/A
- ISPC N/A
- EPS Growth
- NIVF N/A
- ISPC N/A
- EPS
- NIVF N/A
- ISPC N/A
- Revenue
- NIVF $5,679,218.00
- ISPC $10,390,702.00
- Revenue This Year
- NIVF N/A
- ISPC $13.82
- Revenue Next Year
- NIVF N/A
- ISPC $11.76
- P/E Ratio
- NIVF N/A
- ISPC N/A
- Revenue Growth
- NIVF N/A
- ISPC 0.74
- 52 Week Low
- NIVF $0.24
- ISPC $2.76
- 52 Week High
- NIVF $17.24
- ISPC $12.20
- Technical
- Relative Strength Index (RSI)
- NIVF 44.71
- ISPC 35.73
- Support Level
- NIVF $0.30
- ISPC $2.80
- Resistance Level
- NIVF $0.43
- ISPC $3.97
- Average True Range (ATR)
- NIVF 0.08
- ISPC 0.56
- MACD
- NIVF 0.01
- ISPC -0.07
- Stochastic Oscillator
- NIVF 45.05
- ISPC 1.56
About NIVF NEWGENIVF GROUP LIMITED
NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.